Results 191 to 200 of about 15,700 (277)

A phase 1 study of the breast milk and plasma pharmacokinetics of zavegepant 10 mg intranasal dose in healthy lactating women

Headache: The Journal of Head and Face Pain, Volume 66, Issue 5, Page 1050-1057, May 2026.
Abstract Objective This study evaluated the pharmacokinetics of zavegepant in human breast milk and plasma following a single, 10 mg dose of zavegepant nasal spray. Background Zavegepant nasal spray is a member of the gepant class of medications; small molecule inhibitors of the calcitonin gene‐related peptide receptor.
Abhijeet Jakate, Yan Weng, Ani Shkrodova, Ogert Fisniku, Ding Ding, Kayce Morton, Benjamin Maligalig, Pamela Garnick, Jing Liu, Mohamed H. Shahin   +9 more
wiley   +1 more source

Nasal Spray Dosage Form [PDF]

, 2020
openaire   +1 more source

Reversible cerebral vasoconstriction syndrome: A narrative review

Headache: The Journal of Head and Face Pain, Volume 66, Issue 5, Page 1162-1180, May 2026.
Abstract Objectives/Background This review summarizes current insights into Reversible cerebral vasoconstriction syndrome (RCVS) diagnosis, management, and outcomes. RCVS is a cerebrovascular disorder characterized by recurrent thunderclap headaches and transient segmental vasoconstriction of cerebral arteries, typically resolving within 3 months ...
Ícaro Araújo de Sousa, Abner da Silva Machado, Arthur de Oliveira Veras, Thiago Oscar Goulart, Sarah Galassi Tatsuta, Trajano Aguiar Pires Gonçalves, Eva Rocha, Octávio Marques Pontes‐Neto   +7 more
wiley   +1 more source

COVID-19: Azelastine nasal spray Reduces Virus-load In Nasal swabs (CARVIN). Early intervention with azelastine nasal sprays reduces viral load in SARS-CoV-2 infected patients. First report on a double-blind placebo-controlled phase II clinical trial.

, 2021
Klussmann JP, Lehmann C, Grosheva M, Sahin K, Nagy E, Szijártó V, Nagy G, Konrat R, Meiser P, Flegel M, de Aragão PA, Morr H, Saleh HA, Russo B, Müller-Scholtz S, Allekotte S, Moesges R.   +16 more
europepmc   +1 more source

Risk of contamination of nasal sprays in otolaryngologic practice [PDF]

Erdinc Aydin, Evren Hizal, Babur Akkuzu, Ozlem Azap   +3 more
core   +1 more source

Oxytocin nasal spray in fibromyalgic patients: additional information : reply to the comment to the editor entitled "future directions for the investigation of intranasal oxytocin and pain" [PDF]

, 2014
Agabio, R, Mameli, S, Melis, MR, Minerba, L, Sardo, S   +4 more
core   +1 more source

Intranasal drug delivery: Unlocking the nose-to-brain route for central nervous system therapies. [PDF]

Int J Pharm X
Alwali B, Parumasivam T, Al-Tabakha MM.
europepmc   +1 more source

Granisetron Hydrochloride Nasal Spray [PDF]

, 2020
openaire   +1 more source

Regional Nasal Drug Deposition in Pediatric vs. Adult Models: In vitro Insights into User Technique and Breathing Patterns Sensitivity. [PDF]

Pharm Res
Hejazi M, Owen X, Edwards DJ, Hindle M, Longest W, Schuman T, Walenga R, Chopski S, Kaviratna A, Newman B, Golshahi L.   +10 more
europepmc   +1 more source

Dexmedetomidine nasal spray for patients undergoing endoscopic retrograde cholangiopancreatography: protocol for a randomized controlled trial. [PDF]

Ann Med
Zhuang MY, Xu LN, Lv J, Liu LL, Lu YD, Ji FH, Sudhan N, Huang L, Peng K.   +8 more
europepmc   +1 more source